Novartis AG is 148.5x more valuable than OCULAR THERAPEUTIX, INC by market capitalization ($283.13 B vs $1.91 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OCUL | NVS |
|---|---|---|
| Market cap | $1.91 B | $283.13 B |
| US-listed rank | #2122 | #47 |
| Revenue (latest FY) | $51.95M | - |
| Net income (latest FY) | -$265.94M | - |
| Net margin | -511.9% | - |
| SEC filings | 827 | 947 |
Novartis AG is 148.5x more valuable than OCULAR THERAPEUTIX, INC by market capitalization ($283.13 B vs $1.91 B).
Full pages: OCULAR THERAPEUTIX, INC and Novartis AG, or browse the full rankings.